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ABSTRACT
There is accumulating evidence ascribing the health potential of biologically active 
aglycone isoflavones in soy. The isoflavones in soy however exist predominantly in the 
inactive glucoside form. Several studies strongly supported the action of probiotics, 
mainly lactic acid bacteria (LAB) that possess /3-glucosidase which hydrolyses glucosides 
to biologically potent aglycones during soymilk fermentation. In the present study, 12 
LAB (lactobacilli and pediococci) isolated from Malaysian fermented food or milk 
products that possess probiotic characteristics were evaluated for their ability to ferment 
soymilk and hydrolyse glucosides to biologically potent aglycones. The soymilk 
fermented with LAB was assessed for their antioxidant properties in vitro and in vivo. 
Soymilk fermented with selected LAB were further assessed for antiproliferative effect in 
vitro and inhibition of aberrant crypt foci (ACF) formation in azoxymethane (AOM)- 
induced colonic neoplastic rats. The safety status of soymilk fermented with LAB was 
determined through acute and subchronic toxicity studies. The unfermented (negative 
control) and soymilk fermented with L. casei LABPC (positive control) were used as 
controls in the present study. The results showed that soymilk supported the growth of 
LAB. The level of bioactive aglycones in soymilk was enhanced (P<0.05) between 50 to 
90% after 48 h of fermentation with the 12 LAB or LABPC. The total phenol content 
increased (P<0.05) only in soymilk fermented with L. fermentum LAB 9 (58.68 mg 
gallic acid/100 mL) as compared to the unfermented soymilk (51.92 mg gallic acid/100 
mL). DPPH radical-scavenging activity of soymilk fermented with the 12 LAB (75- 
100%) was significantly (P<0.05) greater than that of the unfermented soymilk (62%) at 
48 h. The ferrous ion chelating effect was enhanced (P<0.05) in soymilk fermented with 
Lactobacillus sp. LAB 1 (65%), LAB 12 (63%), P. pentosaceus LAB 7 and LAB 8 (64- 
67%) after 48 h of incubation. The ethyl acetate extracts of supernatant (EAS) and cell 
fractions (EAC) of LAB fermented soymilk exhibited significantly (P<0.05) higher 
antiproliferative effect as compared to the unfermented soymilk extracts against human 
colorectal cancer cells (HCT116 and HT-29). The soymilk fermented with P. 
pentosaceus LAB 8 and Lactobacillus sp. LAB 12 that exerted strong antiproliferative 
effect in vitro also showed chemopreventive effect against colon carcinogenesis in AOM- 
induced rats. Total number of ACF was significantly (P<0.05) lower in rats fed with 
soymilk fermented with P. pentosaceus LAB 8 and Lactobacillus sp. LAB 12 (77-87%) 
than that of the control (saline, 57-66%) or LABPC group (73-74%). In vivo antioxidant 
activities (SOD, CAT and GPx) were enhanced in AOM-induced rats fed soymilk 
fermented with LAB or LABPC. The LAB fermented soymilk also showed 
hypocholesterolemic effect. Furthermore, incorporation of LAB in the diets at the dose 
of 109 and 1010 cells daily for 28 days did not show any significant differences on 
behavior, general health status, body weight and blood analysis in all the treated groups 
as compared with control, suggesting that the safety characteristics of the LAB strains 
(LAB8 and LAB 12). This study indicates that LAB has the potential to enrich bioactive 
isoflavones in soymilk and possess promising antioxidative and antiproliferative 
activities to improve the nutritional value of soymilk.
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